Cabana Jérôme, Holleran Brian, Leduc Richard, Escher Emanuel, Guillemette Gaétan, Lavigne Pierre
Departments of Pharmacology, Faculty of Medicine and Health Sciences, Institut de Pharmacologie de Sherbrooke, Université de Sherbrooke, Sherbrooke, Quebec J1H 5N4; PROTEO (Quebec Network on Protein Structure, Function, and Engineering), Université Laval, Québec, Québec G1V 0A6, Canada.
Departments of Pharmacology, Faculty of Medicine and Health Sciences, Institut de Pharmacologie de Sherbrooke, Université de Sherbrooke, Sherbrooke, Quebec J1H 5N4.
J Biol Chem. 2015 Jun 19;290(25):15835-15854. doi: 10.1074/jbc.M114.627356. Epub 2015 May 1.
Biased signaling represents the ability of G protein-coupled receptors to engage distinct pathways with various efficacies depending on the ligand used or on mutations in the receptor. The angiotensin-II type 1 (AT1) receptor, a prototypical class A G protein-coupled receptor, can activate various effectors upon stimulation with the endogenous ligand angiotensin-II (AngII), including the Gq/11 protein and β-arrestins. It is believed that the activation of those two pathways can be associated with distinct conformations of the AT1 receptor. To verify this hypothesis, microseconds of molecular dynamics simulations were computed to explore the conformational landscape sampled by the WT-AT1 receptor, the N111G-AT1 receptor (constitutively active and biased for the Gq/11 pathway), and the D74N-AT1 receptor (biased for the β-arrestin1 and -2 pathways) in their apo-forms and in complex with AngII. The molecular dynamics simulations of the AngII-WT-AT1, N111G-AT1, and AngII-N111G-AT1 receptors revealed specific structural rearrangements compared with the initial and ground state of the receptor. Simulations of the D74N-AT1 receptor revealed that the mutation stabilizes the receptor in the initial ground state. The presence of AngII further stabilized the ground state of the D74N-AT1 receptor. The biased agonist [Sar(1),Ile(8)]AngII also showed a preference for the ground state of the WT-AT1 receptor compared with AngII. These results suggest that activation of the Gq/11 pathway is associated with a specific conformational transition stabilized by the agonist, whereas the activation of the β-arrestin pathway is linked to the stabilization of the ground state of the receptor.
偏向性信号传导是指G蛋白偶联受体根据所使用的配体或受体中的突变,以不同的效力参与不同信号通路的能力。血管紧张素II 1型(AT1)受体是典型的A类G蛋白偶联受体,在内源性配体血管紧张素II(AngII)刺激下可激活多种效应器,包括Gq/11蛋白和β-抑制蛋白。据信,这两条信号通路的激活可能与AT1受体的不同构象有关。为了验证这一假设,我们进行了微秒级的分子动力学模拟,以探索野生型AT1受体、N111G-AT1受体(组成型激活且偏向Gq/11信号通路)和D74N-AT1受体(偏向β-抑制蛋白1和-2信号通路)在无配体状态以及与AngII结合状态下的构象变化情况。与AngII-WT-AT1、N111G-AT1和AngII-N111G-AT1受体的初始和基态相比,分子动力学模拟揭示了特定的结构重排。D74N-AT1受体的模拟结果表明,该突变使受体在初始基态下更加稳定。AngII的存在进一步稳定了D74N-AT1受体的基态。与AngII相比,偏向性激动剂[Sar(1),Ile(8)]AngII也更倾向于野生型AT1受体的基态。这些结果表明,Gq/11信号通路的激活与激动剂稳定的特定构象转变有关,而β-抑制蛋白信号通路的激活则与受体基态的稳定有关。